The US Preventive Services Task Force recommends annual fecal immunochemical test (FIT) as one of the colorectal cancer (CRC) screening tests. 1 Adherence to yearly FIT is crucial to programmatic success. 2 However, longitudinal adherence is low and strategies to improve persistent adherence are needed. 3 We evaluated the effectiveness of interactive telephone calls vs automated short message service (SMS) on improving adherence to FIT screening compared with usual care.
Methods | We conducted a prospective randomized parallel group study, with the setting previously described. 4 The trial was registered on Clinicaltrials.gov (NCT02815436). Asymptomatic patients with negative FIT results in their first screening round from April to September 2015 due for annual screening in 2016 were eligible. Patients who could not understand telephone or SMS, or did not have mobile phones were excluded. Participants were randomized by a computergenerated sequence with an allocation ratio of 1:1:1. In the control group, participants were told in 2015 that they should visit the screening center for annual FIT pickup at the same calendar month of 2016. In the SMS group, subjects received a 1-way SMS, highlighting importance of CRC screening, and notifying date and location of FIT pickup on their mobile. In the telephone group, participants received a call from a trained health care physician with the same message as the SMS, but an interactive conversation was permitted. The interventions were delivered 1 month before the expected date of participant return for second round of screening. The Joint Chinese University of Hong Kong-New Territories East Cluster Clinical Research Ethics Committee approved the study and participant consent was waived because the interventions were an extension of the screening services. The trial protocol is provided in the Supplement. Outcomes were rate of FIT pickup within 1 month of a patient's anticipated return, and rate of FIT return within 2 months of anticipated return. Six hundred patients provide 80% power (at 5% α level) for detecting an 11% increase in FIT return rate in the intervention groups compared with control, which was assumed to have a FIT return rate of 70%.
5 Associations between study groups and outcomes were examined by backward stepwise, binary logistic regression. Subgroup analysis for sex, marital status, household income, and educational level were performed, because these factors were previously found to be associated with screening adherence. Figure) . No statistically significant differences were noted among the groups for participant and clinical characteristics, including age, sex, and sociodemographic variables. The FIT pickup rate was 62.3%, 78.5%, and 89.8% for the control, SMS, and telephone groups, respectively (P < .001) (Table) . Delayed pick up of FIT (ie, 1 month after the anticipated return date) occurred in 10.6%, 6.7%, and 3.4% of the corresponding groups, respectively (P = .02). The FIT return rate was 69.1%, 82.8% and 91.2%, for the respective groups (P < .001). The FIT pickup and return rates were significantly higher in the telephone group compared with the SMS group. Both interventions were more effective for FIT pickup and return than control, with similar unadjusted and adjusted odds ratios. The findings remained significant on subgroup analysis.
Discussion | Nonadherence to longitudinal FIT screening contributes to CRC mortality. 2 Telephone calls and SMS conferred a 5.2-and 2.4-fold higher likelihood of FIT return. Our findings should, however, be interpreted with caution because they could be sensitive to the timeframe when adherence was measured. These strategies acted on the predisposing and reinforcing factor components of the PRECEDE-PROCEED model. Telephone calls were superior to automated 1-way SMS, implying personal interaction with health care professionals enhances adherence. Screening programs in other settings with low adherence should consider telephone-based or SMS strategies to maximize the mortality benefits of screening. Since colonoscopy continues to be the gold-standard screening test in many developed countries and its adherence barriers may be different, the effectiveness of these strategies on enhancing colonoscopy attendance should be evaluated in future studies.
Role of the Funder/Sponsor: The Hong Kong Jockey Club Charities Trust had no involvement in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. In the course of explaining that I understood why one of my patients was concerned about the inclusion of her religious background in her electronic medical record due to the current sociopolitical climate, I included a sentence about a student at my institution having been threatened with being set afire by a stranger for wearing a hijab. The source of this information came from a University of Michigan institutional crime alert that was sent via campus-wide email on November 12, 2016, 2 and subsequent email to the campus community from President Mark Schlissel and other leaders on November 13, 2016. 3 The institution's message stated, "In the days since last Tuesday's election, people in our community have experienced hateful attacks, both on an individual level and as members of groups…We saw a threatening message painted on the rock near our campus; a student walking near campus was threatened with being lighted on fire because she wore a hijab; another student left his apartment to go to class and found a swastika with a message telling him to go home. Some students have also been shouted at and accused of being racist because of their political views." Relying on this information, I submitted my manuscript to JAMA Oncology on December 2, 2016. On December 21, the University of Michigan cancelled the crime alert regarding the incident with the student wearing the hijab because, upon investigation, detectives had determined the incident in question did not occur. 2 The online copy of the November 13, 2016, email from campus leaders that was posted on the internet was thus amended by adding a parenthetical hyperlink to the cancellation notice, "(this crime alert has been canceled)," after the word "hijab." Unlike the original alert and institutional announcement, however, notification of the cancellation and amendment were not emailed to the community, and so I was unaware of the subsequent developments until an astute reader contacted the editors of JAMA Oncology. I have requested that the erroneous sentence be deleted, and the article has been formally corrected.
4 I apologize to the readers and editors of JAMA Oncology for any confusion this may have caused and thank the reader who informed us of the cancellation of the crime alert.
Current Challenges Associated With NextGeneration Sequencing of Breast Cancer
To the Editor I appreciated the nice review of the current status and promise for the use of next-generation sequencing (NGS) in identifying actionable somatic and germline molecular abnormalities as breast cancer therapeutic targets. The authors 1(p262) conclude that "circulating tumor DNA analysis, once sensitive and broad enough" will enable the identification of these actionable abnormalities. Two limitations of NGS of cell-free or circulating tumor DNA not mentioned by Niravath et al 1 are fundamental to interpreting these liquid biopsy specimens. First, NGS assays of liquid biopsy specimens report only apparent somatic mutations in the DNA analyzed. Currently, companies are not licensed or validated to report apparent germline abnormalities. For example, if the submitted sample is determined to carry a relatively high mutation allelic frequency (MAF) in a gene associated with an inherited cancer syndrome (eg, BRCA, PALB2,o rBRIP), this will be unreported. As a result, unless the unreported MAF is specifically requested, clinicians will be unaware of these potentially "actionable" abnormalities. 
